212 related articles for article (PubMed ID: 36168189)
21. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
[TBL] [Abstract][Full Text] [Related]
22. Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore.
Chau YT; Nashi N; Law LS; Goh RKH; Choo SX; Seetharaman SK
Arch Osteoporos; 2020 Sep; 15(1):141. PubMed ID: 32918196
[TBL] [Abstract][Full Text] [Related]
23. Clinical effectiveness of osteoporosis treatment in older patients: A fracture liaison service-based prospective study.
Mugnier B; Daumas A; Couderc AL; Mizzi B; González T; Amrani A; Lévêque P; Aymes B; Argenson JN; Villani P
J Women Aging; 2019; 31(6):553-565. PubMed ID: 30295566
[TBL] [Abstract][Full Text] [Related]
24. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.
Cadarette SM; Solomon DH; Katz JN; Patrick AR; Brookhart MA
Osteoporos Int; 2011 Mar; 22(3):943-54. PubMed ID: 20532481
[TBL] [Abstract][Full Text] [Related]
25. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
Wang Z; Ward MM; Chan L; Bhattacharyya T
Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
[TBL] [Abstract][Full Text] [Related]
26. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
Bonafede MM; Shi N; Bower AG; Barron RL; Grauer A; Chandler DB
Osteoporos Int; 2015 Mar; 26(3):1203-12. PubMed ID: 25567774
[TBL] [Abstract][Full Text] [Related]
27. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
Levis S; Theodore G
J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
[TBL] [Abstract][Full Text] [Related]
28. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
[TBL] [Abstract][Full Text] [Related]
29. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
Modi A; Tang J; Sen S; Díez-Pérez A
Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
[TBL] [Abstract][Full Text] [Related]
30. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
[TBL] [Abstract][Full Text] [Related]
31. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
Wilk A; Sajjan S; Modi A; Fan CP; Mavros P
Osteoporos Int; 2014 Dec; 25(12):2777-86. PubMed ID: 25112720
[TBL] [Abstract][Full Text] [Related]
32. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
[TBL] [Abstract][Full Text] [Related]
33. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
34. The association between osteoporosis medications and lowered all-cause mortality after hip or vertebral fracture in older and oldest-old adults: a nationwide population-based study.
Li CC; Hsu JC; Liang FW; Chang YF; Chiu CJ; Wu CH
Aging (Albany NY); 2022 Mar; 14(5):2239-2251. PubMed ID: 35232893
[TBL] [Abstract][Full Text] [Related]
35. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
36. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures.
Ensrud KE; Ewing SK; Taylor BC; Fink HA; Stone KL; Cauley JA; Tracy JK; Hochberg MC; Rodondi N; Cawthon PM;
J Gerontol A Biol Sci Med Sci; 2007 Jul; 62(7):744-51. PubMed ID: 17634322
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
[TBL] [Abstract][Full Text] [Related]
38. Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019.
Agarwal AR; Cohen JS; Jorgensen A; Thakkar SC; Srikumaran U; Golladay GJ
Osteoporos Int; 2023 Feb; 34(2):379-385. PubMed ID: 36462054
[TBL] [Abstract][Full Text] [Related]
39. Real-World Management of Patients With Osteoporosis at Very High Risk of Fracture.
Diffenderfer BW; Wang Y; Pearman L; Pyrih N; Williams SA
J Am Acad Orthop Surg; 2023 Mar; 31(6):e327-e335. PubMed ID: 36791248
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Various Anti-Osteoporosis Drugs on All-Cause Mortality After Hip Fractures: A Nationwide Population Study.
Tai TW; Hwang JS; Li CC; Hsu JC; Chang CW; Wu CH
J Bone Miner Res; 2022 Aug; 37(8):1520-1526. PubMed ID: 35689432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]